MedPath

Economic and Social Disparities and Breast Cancer

Completed
Conditions
Breast Cancer
Interventions
Other: Exposed
Other: Non exposed
Registration Number
NCT02948478
Lead Sponsor
Assistance Publique - H么pitaux de Paris
Brief Summary

Precariousness is a multifactorial concept that can be broken down in the form of economic insecurity, and / or social insecurity and / or territorial insecurity. Precariousness has an impact on health that is difficult to assess precisely because it also impacts on other factors that may themselves influence health. Therefore, the understanding of the impact of precariousness on health involves studying individuals in their context.

Our study is designed to assess the impact of precariousness on the history of breast cancer, on care pathways, on treatment and rehabilitation in a multidisciplinary contextual analysis. Indeed, the socio -economic and geographical inequalities affect the history of breast cancer, treatment and its delay and post- treatment rehabilitation.

The main objective of this project is to compare the stage of disease at diagnosis (according to the TNM classification) in deprived and non deprived patients. The secondary objectives are to compare in the two groups - the socio-economic and geographical inequalities - the direct and indirect costs related to the management, the out-of pocket costs and to describe, based on individual inequalities identified, the pathway of care of the patient.

These objectives will be pursued in the framework of an observational cohort study, prospective, multicenter (Ile de France) comparative exposed / unexposed category. Each precarious patient will be matched to a non- precarious patient in the same age group, regardless of the center. The study will include any patient resident in Ile de France seeking treatment for breast cancer, regardless of the stage.

Detailed Description

All patients seeking treatment for breast cancer, regardless of the stage, can be included in the study. Three scores of precariousness will be applied to all patients (EPICES score, Pascal score and the European Deprivation Index). Patients identified as precarious by at least one of those three scales will be in the exposed group. The others will be in the non-exposed group.

Baseline assessment T0:

Are required only the clinical examination and radiological evaluation with the tumor size and node involvement according to TNM classification. A questionnaire will be distributed including EPICES score, Pascal score and European Deprivation Index. The baseline questionnaire will also assess the socio-economic characteristics of patients and the care trajectory before arriving in the center (see appendix).

Follow-up visits:

The following questionnaire will be distributed during a consultation that is scheduled in the routine care. There will be no additional consultation imposed on the patient.

* T1: questionnaire at 3 months after inclusion

* T2: questionnaire at 6 months after inclusion

* T3: questionnaire at 12 months after inclusion

Questionnaires will be focused on direct-costs and out-of-pocket costs, socio-economical characteristics, rehabilitation, return to work.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
936
Inclusion Criteria
  • Patients ? 18 years old having a breast cancer histologically proved
Exclusion Criteria
  • Patients with a history of cancer treated in the previous five years, or with another associated untreated cancer

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Precarious patientsExposedPrecarious patients - exposed - will be those identified as precarious by at least one of the three scores (EPICES, Pascal, European Deprivation Index)
Non precarious patientsNon exposedNon precarious patient - non exposed - will be all the patients identified as non-precarious by the three scores (EPICES, Pascal, European Deprivation Index)
Primary Outcome Measures
NameTimeMethod
TNM stageBaseline

TNM classification according to initial clinical and radiological assessment

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (24)

Centre Hopitalier Victor Dupouy Argenteuil

馃嚝馃嚪

Argenteuil, France

H么pital Jean Verdier

馃嚝馃嚪

Bondy, France

Hopital Priv茅 Paule Egine

馃嚝馃嚪

Champigny-sur-Marne, France

Centre Hospitalier de Pontoise

馃嚝馃嚪

Cergy-Pontoise, France

CH Sud Francilien

馃嚝馃嚪

Corbeil-Essonnes, France

Centre Hospitalier Intercommunal Cr茅teil

馃嚝馃嚪

Creteil, France

H么pital Henri Mondor

馃嚝馃嚪

Cr茅teil, France

Clinique Claude Bernard

馃嚝馃嚪

Ermont, France

H么pital Bic锚tre

馃嚝馃嚪

Le Kremlin-Bic锚tre, France

CH de Lagny sur Marne

馃嚝馃嚪

Lagny-sur-Marne, France

Institut de Canc茅rologie Hartmann

馃嚝馃嚪

Levallois-Perret, France

H么pital Saint-Louis

馃嚝馃嚪

Paris, France

Institut Curie H么pital de Paris

馃嚝馃嚪

Paris, France

H么pital Priv茅 des Peupliers

馃嚝馃嚪

Paris, France

H么pital Tenon

馃嚝馃嚪

Paris, France

HEGP

馃嚝馃嚪

Paris, France

Groupe Hospitalier Paris Saint-Joseph

馃嚝馃嚪

Paris, France

Institut de canc茅rologie Paris Nord

馃嚝馃嚪

Sarcelles, France

Clinique de l'Estr茅e

馃嚝馃嚪

Stains, France

Centre Hospitalier de Versailles

馃嚝馃嚪

Versailles, France

Centre Hospitalier Intercommunal Poissy Saint Germain en Laye

馃嚝馃嚪

Poissy, France

Institut Curie H么pital Ren茅-Huguenin site Saint-Cloud

馃嚝馃嚪

Saint-Cloud, France

H么pital Lariboisi猫re

馃嚝馃嚪

Paris, France

Centre Hospitalier Delafontaine

馃嚝馃嚪

Saint-Denis, France

漏 Copyright 2025. All Rights Reserved by MedPath